Physiomics PLC (PYC)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.27p

Buy

0.30p

arrow-up0.005p (+1.75%)

Prices updated at 16 Dec 2025, 12:24 GMT

Prices minimum 15 mins delay

Prices in GBX

Physiomics PLC is engaged in providing outsourced systems and computational biology services to pharmaceutical companies.

FTSE All-Share

-0.58%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Dr. James Simon Millen

CEO

Dr. Peter Joseph Sargent

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

10

Head office

140 Eastern Avenue

Abingdon

United Kingdom

OX14 4SB

-

investors@physiomics.co.uk

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. James Simon Millen Non-Executive Director, Chairman	-
Dr. Peter Joseph Sargent Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
No data

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.